BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Legan M, Luzar B, Marolt VF, Cör A. Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions. World J Gastroenterol 2006; 12(21): 3425-3429 [PMID: 16733863 DOI: 10.3748/wjg.v12.i21.3425]
URL: https://www.wjgnet.com/1007-9327/full/v12/i21/3425.htm
Number Citing Articles
1
Minsub Shim, Julie Foley, Colleen Anna, Yuji Mishina, Thomas Eling. Embryonic Expression of Cyclooxygenase-2 Causes Malformations in Axial SkeletonJournal of Biological Chemistry 2010; 285(21): 16206 doi: 10.1074/jbc.M109.078576
2
Agnès Maillet, Shazib Pervaiz. Redox Regulation of p53, Redox Effectors Regulated by p53: A Subtle BalanceAntioxidants & Redox Signaling 2012; 16(11): 1285 doi: 10.1089/ars.2011.4434
3
Chong-Fei Huang, Jun-Jun Huang, Ning-Ning Mi, Yan-Yan Lin, Qiang-Sheng He, Ya-Wen Lu, Ping Yue, Bing Bai, Jin-Duo Zhang, Chao Zhang, Teng Cai, Wen-Kang Fu, Long Gao, Xun Li, Jin-Qiu Yuan, Wen-Bo Meng. Associations between serum uric acid and hepatobiliary-pancreatic cancer: A cohort studyWorld Journal of Gastroenterology 2020; 26(44): 7061-7075 doi: 10.3748/wjg.v26.i44.7061
4
Deepika Dhawan, Antonella Borgatti Jeffreys, Rong Zheng, Jane C. Stewart, Deborah W. Knapp. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cellsMolecular Cancer Therapeutics 2008; 7(4): 897 doi: 10.1158/1535-7163.MCT-07-0313
5
Marketa Hermanova, Jan Trna, Rudolf Nenutil, Petr Dite, Zdenek Kala. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesionsEuropean Journal of Gastroenterology & Hepatology 2008; 20(8): 732 doi: 10.1097/MEG.0b013e3282f945fb
6
Do‐Hee Kim, Joydeb Kumar Kundu, Young‐Joon Surh. Redox modulation of p53: Mechanisms and functional significanceMolecular Carcinogenesis 2011; 50(4): 222 doi: 10.1002/mc.20709
7
Weiqin Lu, Aihemaitijiang Aihaiti, Paziliya Abudukeranmu, Yajun Liu, Huihui Gao. Arachidonic acid metabolism as a novel pathogenic factor in gastrointestinal cancersMolecular and Cellular Biochemistry 2024;  doi: 10.1007/s11010-024-05057-2
8
Hou-Shan Yao, Chang Sun, Xin-Xing Li, Yi Wang, Kai-Zhou Jin, Xiao-Ping Zhang, Zhi-Qian Hu. Annexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancerScientific Reports 2016; 6(1) doi: 10.1038/srep31056
9
Haeryoung Kim, Joo-Yeon Song, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han, Hye Seung Lee, Han Suk Ryu, Gheeyoung Choe. Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosisJournal of Clinical Pathology 2010; 63(12): 1048 doi: 10.1136/jcp.2010.080713
10
Juan Carlos Roa, Nora Katabi, N. Volkan Adsay. Molecular Pathology of Liver DiseasesMolecular Pathology Library 2011; 5: 891 doi: 10.1007/978-1-4419-7107-4_61
11
Erdenebulgan Batmunkh, Mitsuo Shimada, Yuji Morine, Satoru Imura, Hirofumi Kanemura, Yusuke Arakawa, Jun Hanaoka, Mami Kanamoto, Koji Sugimoto, Masaaki Nishi. Expression of hypoxia-inducible factor-1 alpha (HIF-1α) in patients with the gallbladder carcinomaInternational Journal of Clinical Oncology 2010; 15(1): 59 doi: 10.1007/s10147-009-0011-7
12
Evan Sica, Karen T. Shore, Limin Yang, Kara Chan Phelps, Suntrea T. G. Hammer, Purva Gopal, Dipti M. Karamchandani, James Michael Mitchell. Utility of IMP3, p53, and S100P immunohistochemical stains in distinguishing reactive atypia from dysplasia in cholecystectomy specimensDiagnostic Pathology 2024; 19(1) doi: 10.1186/s13000-024-01550-w
13
Mateja Legan, Boštjan Luzar, Vera Ferlan Marolt. Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosisScandinavian Journal of Gastroenterology 2009; 44(9): 1101 doi: 10.1080/00365520903121685
14
Eduardo E. Montalvo-Jave, Amir A. Rahnemai- Azar, Dimitrios Papaconstantinou, Mariana Espejel Deloiza, Diamantis I. Tsilimigras, Dimitrios Moris, German Eduardo Mendoza-Barrera, Sharon M. Weber, Timothy M. Pawlik. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive reviewSurgical Oncology 2019; 31: 83 doi: 10.1016/j.suronc.2019.09.006
15
Deepika Dhawan, Bruce A. Craig, Liang Cheng, Paul W. Snyder, Sulma I. Mohammed, Jane C. Stewart, Rong Zheng, Rhoda A. Loman, Richard S. Foster, Deborah W. Knapp. Effects of Short-term Celecoxib Treatment in Patients with Invasive Transitional Cell Carcinoma of the Urinary BladderMolecular Cancer Therapeutics 2010; 9(5): 1371 doi: 10.1158/1535-7163.MCT-10-0049
16
Juan Carlos Roa, N. Volkan Adsay. Molecular Surgical Pathology2013; : 65 doi: 10.1007/978-1-4614-4900-3_4
17
Eric I Marks, Nelson S Yee. Molecular genetics and targeted therapeutics in biliary tract carcinomaWorld Journal of Gastroenterology 2016; 22(4): 1335-1347 doi: 10.3748/wjg.v22.i4.1335
18
Guo-shun Shu, Fang Lv, Zhu-lin Yang, Xiong-ying Miao. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significancesInternational Journal of Clinical Oncology 2013; 18(4): 641 doi: 10.1007/s10147-012-0431-7
19
Bridget C. Lynch, Sarah L. Lathrop, Dongmei Ye, Thomas Y. Ma, Lisa A. Cerilli. Expression of the p16(INK4a) gene product in premalignant and malignant epithelial lesions of the gallbladderAnnals of Diagnostic Pathology 2008; 12(3): 161 doi: 10.1016/j.anndiagpath.2007.06.003
20
Jaime A. Espinoza, Carolina Bizama, Patricia García, Catterina Ferreccio, Milind Javle, Juan F. Miquel, Jill Koshiol, Juan C. Roa. The inflammatory inception of gallbladder cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016; 1865(2): 245 doi: 10.1016/j.bbcan.2016.03.004
21
Emanuela de Moraes, Nazir Ahmad Dar, Claudia Vitoria de Moura Gallo, Pierre Hainaut. Cross‐talks between cyclooxygenase‐2 and tumor suppressor protein p53: Balancing life and death during inflammatory stress and carcinogenesisInternational Journal of Cancer 2007; 121(5): 929 doi: 10.1002/ijc.22899
22
Jorge Albores-Saavedra, Arturo Angeles-Angeles. MacSween's Pathology of the Liver2012; : 563 doi: 10.1016/B978-0-7020-3398-8.00011-8
23
Maria Diab, Philip A. Philip. Textbook of Gastrointestinal Oncology2019; : 197 doi: 10.1007/978-3-030-18890-0_12
24
Xiaodong Teng. Intraepithelial Neoplasia2009; : 112 doi: 10.1007/978-3-540-85453-1_3
25
James F. Watkins, Matthew S. Mayo, Holly J. Smith, Stephen K. Williamson. Gemcitabine, irinotecan and celecoxib in patients with biliary cancerAnti-Cancer Drugs 2009; 20(4): 294 doi: 10.1097/CAD.0b013e3283287ca0
26
Xiaoling Song, Yunping Hu, Yongsheng Li, Rong Shao, Fatao Liu, Yingbin Liu. Overview of current targeted therapy in gallbladder cancerSignal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00324-2
27
Robert David Goldin, Juan Carlos Roa. Gallbladder cancer: a morphological and molecular updateHistopathology 2009; 55(2): 218 doi: 10.1111/j.1365-2559.2008.03192.x
28
Sung-Im Do, Gou Young Kim, Sung-Jig Lim, Youn Wha Kim. Expression of Cyclooxygenase-2 and Embryonic Lethal Abnormal Vision-Like Protein HuR in Gallbladder CarcinomaThe Korean Journal of Pathology 2010; 44(1): 42 doi: 10.4132/KoreanJPathol.2010.44.1.42
29
S.G. Barreto, A. Dutt, A. Chaudhary. A genetic model for gallbladder carcinogenesis and its disseminationAnnals of Oncology 2014; 25(6): 1086 doi: 10.1093/annonc/mdu006
30
Ioannis S. Pateras, Ana Igea, Ilias P. Nikas, Danai Leventakou, Nektarios I. Koufopoulos, Argyro Ioanna Ieronimaki, Anna Bergonzini, Han Suk Ryu, Antonios Chatzigeorgiou, Teresa Frisan, Christos Kittas, Ioannis G. Panayiotides. Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive SystemInternational Journal of Molecular Sciences 2024; 25(2): 1251 doi: 10.3390/ijms25021251